Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
M. Gosset-Woimant, C. Andrejak, C. Poulet, D. Basille, H. Bentayeb, M. Boutemy, E. Lecuyer, S. Thielen, N. Benoit, J. Montconduit, F. Martin, O. Leleu, C. Clarot, V. Jounieaux, C. Dayen, Y. Douadi (Amiens, Saint Quentin, Compiègne, Abbeville, France)
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Gosset-Woimant, C. Andrejak, C. Poulet, D. Basille, H. Bentayeb, M. Boutemy, E. Lecuyer, S. Thielen, N. Benoit, J. Montconduit, F. Martin, O. Leleu, C. Clarot, V. Jounieaux, C. Dayen, Y. Douadi (Amiens, Saint Quentin, Compiègne, Abbeville, France). Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients. Eur Respir J 2009; 34: Suppl. 53, 2379
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Predictors of outcome in parapneumonic pleural effusions in children Source: Eur Respir J 2001; 18: Suppl. 33, 171s Year: 2001
Prognostic features of residual pleural thickening after parapneumonic pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 605s Year: 2002
Prognostic features of residual pleural thickening in parapneumonic pleural effusions Source: Eur Respir J 2003; 21: 952-955 Year: 2003
Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011
Management of parapneumonic effusion and empyema in children Source: Eur Respir J 2002; 20: Suppl. 38, 589s Year: 2002
Evaluation of patients with pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 247s Year: 2004
Update on the management of parapneumonic pleural effusions Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021 Year: 2021
Risk factors for parapneumonic effusion in community-asquired pneumonia Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Treatment results of patients with complicated parapneumonic effusion and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 358s Year: 2002
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006
Parapneumonic effusion and empyema Source: Respipedia Article Year: 2017
Treatment of parapneumonic pleural effusion and empyema: conservative view Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199 Year: 2004
Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy Source: Annual Congress 2011 - From outside to inside: access to the pleura Year: 2011
Lung function in children post parapneumonic effusion and empyema Source: Eur Respir J 2002; 20: Suppl. 38, 590s Year: 2002
Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013